Data gathered: November 30
Alternative Data for Ligand Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Employee Rating | 94 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,583 | Sign up | Sign up | Sign up |
| Twitter Followers | 10,683 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 64 | Sign up | Sign up | Sign up |
| Linkedin Employees | 117 | Sign up | Sign up | Sign up |
About Ligand Pharmaceuticals
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide.
| Price | $121.47 |
| Target Price | Sign up |
| Volume | 72,060 |
| Market Cap | $2.32B |
| Year Range | $68.53 - $129.9 |
| Dividend Yield | 0% |
| PE Ratio | 49.22 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives $144.83 Consensus Target Price from AnalystsNovember 24 - ETF Daily News |
 |
Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of TherapiesNovember 23 - SeekingAlpha |
|
Royce & Associates LP Trims Stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)November 21 - ETF Daily News |
|
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Acquired by Atria Investments IncNovember 21 - ETF Daily News |
 |
Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid EarningsNovember 15 - Yahoo |
 |
LGND: 3Q Sales Surprise to the UpsideNovember 10 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 52M | 35M | 17M | -7.2M | 3.1M | 1.840 |
| Q2 '24 | 42M | 29M | 13M | -52M | -55M | 1.400 |
| Q1 '24 | 91M | 22M | 69M | 86M | 12M | 1.200 |
| Q4 '23 | 28M | 26M | -35M | 18M | 27M | 1.380 |
| Q3 '23 | 35M | 26M | 8.6M | -10M | 23M | 1.020 |
Insider Transactions View All
| Korenberg Matthew E filed to sell 50,777 shares at $102.1. September 24 '24 |
| Korenberg Matthew E filed to sell 58,068 shares at $100.1. September 24 '24 |
| Korenberg Matthew E filed to sell 50,978 shares at $101.6. September 24 '24 |
| Reardon Andrew filed to sell 22,534 shares at $99.6. September 25 '24 |
| Espinoza Octavio filed to sell 25,685 shares at $104. September 24 '24 |
Similar companies
Read more about Ligand Pharmaceuticals (LGND) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Ligand Pharmaceuticals?
The Market Cap of Ligand Pharmaceuticals is $2.32B.
What is Ligand Pharmaceuticals' PE Ratio?
As of today, Ligand Pharmaceuticals' PE (Price to Earnings) ratio is 49.22.
What is the current stock price of Ligand Pharmaceuticals?
Currently, the price of one share of Ligand Pharmaceuticals stock is $121.47.
How can I analyze the LGND stock price chart for investment decisions?
The LGND stock price chart above provides a comprehensive visual representation of Ligand Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ligand Pharmaceuticals shares. Our platform offers an up-to-date LGND stock price chart, along with technical data analysis and alternative data insights.
Does LGND offer dividends to its shareholders?
As of our latest update, Ligand Pharmaceuticals (LGND) does not offer dividends to its shareholders. Investors interested in Ligand Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ligand Pharmaceuticals?
Some of the similar stocks of Ligand Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.